Guidelines on optimizing the use of proton pump inhibitors : PPI stewardship
© 2023. Indian Society of Gastroenterology..
Proton pump inhibitors (PPIs) have been available for over three decades and are among the most commonly prescribed medications. They are effective in treating a variety of gastric acid-related disorders. They are freely available and based on current evidence, use of PPIs for inappropriate indications and duration appears to be common. Over the years, concerns have been raised on the safety of PPIs as they have been associated with several adverse effects. Hence, there is a need for PPI stewardship to promote the use of PPIs for appropriate indication and duration. With this objective, the Indian Society of Gastroenterology has formulated guidelines on the rational use of PPIs. The guidelines were developed using a modified Delphi process. This paper presents these guidelines in detail, including the statements, review of literature, level of evidence and recommendations. This would help the clinicians in optimizing the use of PPIs in their practice and promote PPI stewardship.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
|---|---|
| Enthalten in: |
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology - 42(2023), 5 vom: 12. Okt., Seite 601-628 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dutta, Amit Kumar [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adverse effects |
|---|
| Anmerkungen: |
Date Completed 07.10.2023 Date Revised 03.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s12664-023-01428-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361962169 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361962169 | ||
| 003 | DE-627 | ||
| 005 | 20231226090240.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s12664-023-01428-7 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1206.xml |
| 035 | |a (DE-627)NLM361962169 | ||
| 035 | |a (NLM)37698821 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dutta, Amit Kumar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Guidelines on optimizing the use of proton pump inhibitors |b PPI stewardship |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.10.2023 | ||
| 500 | |a Date Revised 03.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. Indian Society of Gastroenterology. | ||
| 520 | |a Proton pump inhibitors (PPIs) have been available for over three decades and are among the most commonly prescribed medications. They are effective in treating a variety of gastric acid-related disorders. They are freely available and based on current evidence, use of PPIs for inappropriate indications and duration appears to be common. Over the years, concerns have been raised on the safety of PPIs as they have been associated with several adverse effects. Hence, there is a need for PPI stewardship to promote the use of PPIs for appropriate indication and duration. With this objective, the Indian Society of Gastroenterology has formulated guidelines on the rational use of PPIs. The guidelines were developed using a modified Delphi process. This paper presents these guidelines in detail, including the statements, review of literature, level of evidence and recommendations. This would help the clinicians in optimizing the use of PPIs in their practice and promote PPI stewardship | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Practice Guideline | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Adverse effects | |
| 650 | 4 | |a Contraindications | |
| 650 | 4 | |a Duration | |
| 650 | 4 | |a Inappropriate use | |
| 650 | 4 | |a Indications | |
| 650 | 4 | |a Proton pump inhibitors | |
| 650 | 4 | |a Stewardship | |
| 650 | 7 | |a Proton Pump Inhibitors |2 NLM | |
| 700 | 1 | |a Jain, Abhinav |e verfasserin |4 aut | |
| 700 | 1 | |a Jearth, Vaneet |e verfasserin |4 aut | |
| 700 | 1 | |a Mahajan, Ramit |e verfasserin |4 aut | |
| 700 | 1 | |a Panigrahi, Manas Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Vishal |e verfasserin |4 aut | |
| 700 | 1 | |a Goenka, Mahesh Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Kochhar, Rakesh |e verfasserin |4 aut | |
| 700 | 1 | |a Makharia, Govind |e verfasserin |4 aut | |
| 700 | 1 | |a Reddy, Duvvur Nageshwar |e verfasserin |4 aut | |
| 700 | 1 | |a Kirubakaran, Richard |e verfasserin |4 aut | |
| 700 | 1 | |a Ahuja, Vineet |e verfasserin |4 aut | |
| 700 | 1 | |a Berry, Neha |e verfasserin |4 aut | |
| 700 | 1 | |a Bhat, Naresh |e verfasserin |4 aut | |
| 700 | 1 | |a Dutta, Usha |e verfasserin |4 aut | |
| 700 | 1 | |a Ghoshal, Uday Chand |e verfasserin |4 aut | |
| 700 | 1 | |a Jain, Ajay |e verfasserin |4 aut | |
| 700 | 1 | |a Jalihal, Umesh |e verfasserin |4 aut | |
| 700 | 1 | |a Jayanthi, V |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Ajay |e verfasserin |4 aut | |
| 700 | 1 | |a Nijhawan, Sandeep |e verfasserin |4 aut | |
| 700 | 1 | |a Poddar, Ujjal |e verfasserin |4 aut | |
| 700 | 1 | |a Ramesh, G N |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Shivram P |e verfasserin |4 aut | |
| 700 | 1 | |a Zargar, Showkat |e verfasserin |4 aut | |
| 700 | 1 | |a Bhatia, Shobna |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology |d 1993 |g 42(2023), 5 vom: 12. Okt., Seite 601-628 |w (DE-627)NLM012713031 |x 0975-0711 |7 nnns |
| 773 | 1 | 8 | |g volume:42 |g year:2023 |g number:5 |g day:12 |g month:10 |g pages:601-628 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s12664-023-01428-7 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 42 |j 2023 |e 5 |b 12 |c 10 |h 601-628 | ||